pubs.acs.org/joc
element in life sciences,5 and hence, their preparation has also
become significant.
Unexpected C-Se Cross-Coupling Reaction: Copper
Oxide Catalyzed Synthesis of Symmetrical Diaryl
Selenides via Cascade Reaction of Selenourea with
Aryl Halides/Boronic Acids
Traditional methods for the formation of a C-Se bond
require photochemical or harsh reaction conditions, such as
the use of polar and toxic solvents like HMPA and high
reaction temperatures.6 To overcome these difficulties,
several metal salts such as palladium-,7 nickel-,8 copper-,9
iron-,10 indium-,11 and lanthanum-based12 catalytic systems
have been studied for the synthesis of diaryl selenides.
In the present paper, we report the failure of our attempts to
transform selenourea (2) into the corresponding N,N0-disubsti-
tuted selenourea (3) by the C-N cross-coupling reaction of aryl
halides (1). However, a very interesting result was obtained from
the 1H NMR spectrum, which showed the formation of a product
which no longer contained the NH protons but only aromatic
hydrogens. Absorption corresponding to the NH was not ob-
served in the infrared spectrum and comparison with the known
compounds. On the basis of these results and the mass spectrum,
we propose that the obtained liquid product has the structure 4.
Recently, heterogeneous catalysts have become attractive
both from economic and industrial points of view as compared
to homogeneous catalysts. The high surface area and reactive
morphologies of nanomaterials allow them to be effective
catalysts for organic synthesis.13 Furthermore, heterogeneous
catalysts have also the advantage of easy product purification
and reusability of the catalyst.
V. Prakash Reddy, A. Vijay Kumar, and K. Rama Rao*
Organic Chemistry Division-I, Indian Institute of Chemical
Technology, Hyderabad-500 007, India
Received October 11, 2010
Selenourea is used as an effective selenium surrogate in
the C-Se cross-coupling reaction catalyzed by copper
oxide nanoparticles under ligand free conditions. This
protocol has been utilized for the synthesis of a variety of
symmetrical diaryl selenides in good to excellent yields
from the readily available aryl halides/boronic acids.
In continuation of our interest in the field of cross-
coupling reactions,14 we report herein the CuO nanoparticle-
catalyzed unexpected reaction pattern of selenourea and aryl
(5) (a) Klayman, D. L.; Gunter, H. H. Organoselenium Compounds: Their
Chemistry and Biology; Wiley-Interscience: New York, 1973. (b) Rotruck,
J. T.; Pope, A. L.; Ganther, H. E.; Swanson, A. B.; Hafeman, D. G.;
Hoekstra, W. G. Science 1973, 179, 588. (c) Flohe, L.; Gunzler, E. A.;
Schock, H. H. FEBS Lett. 1973, 32, 132. (d) Shamberger, R. J. Biochemistry
of Selenium; Plenum Press: New York, 1983. (e) Flohe, L.; Andreesen, J. R.;
Brigelius-Flohe, R.; Maiorino, M.; Ursini, F. IUBMB Life 2000, 49, 411.
(6) (a) Suzuki, H.; Abe, H.; Osuka, A. Chem. Lett. 1981, 151. (b) Osuka,
A.; Ohmasa, N.; Suzuki, H. Synth. Commun. 1982, 857. (c) Andersson, C. M.;
Hallberg, A.; Linden, M.; Brattsand, R.; Moldeus, P.; Cotgreave, I. Free
Radic. Biol. Med. 1994, 16, 17. (d) Andersson, C. M.; Hallberg, A.; Hugberg,
T. Adv. Drug Res. 1996, 28, 65.
Organoselenium compounds are not only important re-
agents in organic synthesis1,2 but also serve as potential drug
candidates.3 The biological properties of selenium compounds
have attracted increasing attention due to their antioxidant,
anticancer, antitumor, and antiviral properties.4 In addition,
organoselenium compounds offer chemo-, regio-, and stereo-
selective reactions and selenium is known as a fundamental
(1) (a) Krief, A.; Hevesi, L. Organoselenium Chemistry I; Springer: Berlin,
1988. (b) Comasseto, J. V.; Ling, L. W.; Petragnani, N.; Stefani, H. A.
Synthesis 1997, 373. (c) Organoselenium Chemistry: A Practical Approach;
Back, T. G., Ed.; Oxford University Press: Oxford, UK, 1999. (d) Procter,
D. J. J. Chem. Soc., Perkin Trans. 1 2000, 835.
(7) (a) Nishiyama, Y.; Tokunaga, K.; Sonoda, N. Org. Lett. 1999, 1, 1725.
(b) Beletskaya, I. P.; Sigeev, A. S.; Peregudov, A. S.; Petrovskii, P. V.
J. Organomet. Chem. 2000, 96, 605.
(8) Cristau, H. J.; Chabaud, B.; Labaudiniere, R.; Christol, H. Organo-
metallics 1985, 4, 657.
(2) (a) Braga, A. L.; Ludtke, D. S.; Vargas, F.; Braga, R. C. Synlett 2006,
1453. (b) Braga, A. L.; Vargas, F.; Sehnem, J. A.; Braga, R. C. J. Org. Chem.
2005, 70, 9021. (c) Braga, A. L.; Paixao, M. W.; Ludtke, D. S.; Silveira, C. C.;
Rodrigues, O. E. D. Org. Lett. 2003, 5, 3635. (d) Braga, A. L.; Silva, S. J. N.;
Ludtke, D. S.; Drekener, R. L.; Silveira, C. C.; Rocha, J. B. T.; Wessjohann,
L. A. Tetrahedron Lett. 2002, 43, 7329. (e) Braga, A. L.; Paixao, M. W.;
Marin, G. Synlett 2005, 1975. (f) Braga, A. L.; Ludtke, D. S.; Sehnem, J. A.;
Alberto, E. E. Tetrahedron 2005, 61, 11664.
(3) (a) Sarma, B. K.; Mugesh, G. Org. Biomol. Chem. 2008, 6, 965.
(b) Nogueira, C. W.; Zeni, G.; Rocha, J. B. Chem. Rev. 2004, 104, 6255.
(c) Mugesh, G.; du Mont, W. W.; Sies, H. Chem. Rev. 2001, 101, 2125.
(d) Mugesh, G.; Singh, H. B. Chem. Soc. Rev. 2000, 29, 347.
(4) (a) Back, T. G.; Moussa, Z. J. Am. Chem. Soc. 2003, 125, 13455.
(b) Nogueira, C. W.; Zeni, G.; Rocha, J. B. T. Chem. Rev. 2004, 104, 6255.
(c) Anderson, C.-M.; allberg, A.; Hogberg, T. Adv. Drug Res. 1996, 28, 65.
(d) Clark, L. C.; Combs, G. F.; Turnbull, B. W.; Slate, E. H.; Chalker, D. K.;
Chow, J.; Davis, L. S.; Glover, R. A.; Graham, G. F.; Gross, E. G.;
Krongrad, A.; Lesher, J. L.; Park, K.; Sanders, B. B.; Smith, C. L.; Taylor,
R. J. Am. Med. Assoc. 1996, 276, 1957. (e) Woods, J. A.; Hadfield, J. A.;
McGown, A. T.; Fox, B. W. Org. Biomol. Chem. 1993, 1, 333.
(9) (a) Bhadra, S.; Saha, A.; Ranu, B. C. J. Org. Chem. 2010, 75, 4864. (b)
Singh, D.; Alberto, E. E.; Rodrigues, O. E. D.; Braga, A. L. Green Chem.
2009, 11, 1521. (c) Alves, D.; Santos, C. G.; Paixao, M. W.; Soares, L. C.; de
Souza, D.; Rodrigues, O. E. D.; Braga, A. L. Tetrahedron Lett. 2009, 50,
6635. (d) Saha, A.; Saha, D.; Ranu, B. C. Org. Biomol. Chem. 2009, 7, 1652.
(e) Taniguchi, N.; Onami, T. J. Org. Chem. 2004, 69, 915. (f) Kumar, S.;
Engman, L. J. Org. Chem. 2006, 71, 5400. (g) Taniguchi, N. J. Org. Chem.
2007, 72, 1241. (h) Gujadhur, R. K.; Venkataraman, D. Tetrahedron Lett.
2003, 44, 81. (i) Beletskaya, I. P.; Sigeev, A. S.; Peregudov, A. S.; Petrovskii,
P. V. Tetrahedron Lett. 2003, 44, 7039. (j) Wang, L.; Wang, M.; Huang, F.
Synlett 2005, 2007. (k) Chang, D.; Bao, W. Synlett 2006, 1786. (l) Taniguchi,
N.; Onami, T. Synlett 2003, 829. (m) Taniguchi, N. Synlett 2005, 1687.
(10) Wang, M.; Ren, K.; Wang, L. Adv. Synth. Catal. 2009, 351, 1586.
(11) Ren, K.; Wang, M.; Wang, L. Org. Biomol. Chem. 2009, 7, 4858.
(12) Murthy, S. N.; Madhav, B.; Reddy, V. P.; Nageswar, Y. V. D. Eur.
J. Org. Chem. 2009, 5902.
(13) (a) Pacchioni, G. Surf. Rev. Lett. 2000, 7, 277. (b) Knight, W. D.;
Clemenger, K.; de Heer, W. A.; Saunders, W. A. M.; Chou, Y.; Cohen, M. L.
Phys. Rev. Lett. 1984, 52, 2141. (c) Kaldor, A.; Cox, D.; Zakin, M. R. Adv.
Chem. Phys. 1988, 70, 211.
8720 J. Org. Chem. 2010, 75, 8720–8723
Published on Web 11/23/2010
DOI: 10.1021/jo102017g
r
2010 American Chemical Society